Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Levin Andersen

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 StudyMarta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen, et al.
Cancers|December 9, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone DiseaseMartin Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2024
Multidisciplinary team approach for CKD-associated osteoporosisDitte Hansen, Hanne Skou Jørgensen, Thomas Levin Andersen, et al.
The Journal of Clinical Investigation|August 16, 2011
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and miceAlexander David Barrow, Nicolas Raynal, Thomas Levin Andersen, et al.
Bone Research|April 1, 2025
KIAA1199 (CEMIP) regulates adipogenesis and whole-body energy metabolismLi Chen, Kaikai Shi, Nicholas Ditzel, et al.
Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Bone|September 25, 2025
Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical studyMette Bøegh Levring, Marta Diaz-delCastillo, Michael Tveden Gundesen, et al.
Molecular Cell|November 26, 2024
The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivoAnna Constance Vind, Zhenzhen Wu, Muhammad Jasrie Firdaus, et al.
Bone Research|June 14, 2026
An ITGA11 expressing subpopulation as predictor for the donor-specific osteogenic capacity of stromal cellsAli Jasim Mohammad Jamil, Kaja Madsen, Souad Daamouch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 16, 2026
Complement factor H (CFH), an immune factor enhances osteoblast differentiation and correlates with bone densityLi Chen, Huimin Hu, Weimin Qiu, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 StudyMarta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen, et al.
Cancers|December 9, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone DiseaseMartin Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2024
Multidisciplinary team approach for CKD-associated osteoporosisDitte Hansen, Hanne Skou Jørgensen, Thomas Levin Andersen, et al.
The Journal of Clinical Investigation|August 16, 2011
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and miceAlexander David Barrow, Nicolas Raynal, Thomas Levin Andersen, et al.
Bone Research|April 1, 2025
KIAA1199 (CEMIP) regulates adipogenesis and whole-body energy metabolismLi Chen, Kaikai Shi, Nicholas Ditzel, et al.
Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Bone|September 25, 2025
Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical studyMette Bøegh Levring, Marta Diaz-delCastillo, Michael Tveden Gundesen, et al.
Molecular Cell|November 26, 2024
The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivoAnna Constance Vind, Zhenzhen Wu, Muhammad Jasrie Firdaus, et al.
Bone Research|June 14, 2026
An ITGA11 expressing subpopulation as predictor for the donor-specific osteogenic capacity of stromal cellsAli Jasim Mohammad Jamil, Kaja Madsen, Souad Daamouch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 16, 2026
Complement factor H (CFH), an immune factor enhances osteoblast differentiation and correlates with bone densityLi Chen, Huimin Hu, Weimin Qiu, et al.
Pageof 6